---
title: "Moise Bioty Kean recovers from injury and set to return with Como"
url: "https://riyadaty.com/en/news/moise-bioty-kean-recovers-from-injury-and-set-to-return-with-como"
language: "en"
description: "Moise Bioty Kean has returned to training after recovering from a leg injury that ruled him out for 3 days, as he prepares for the match against Torino in…"
---

# Moise Bioty Kean recovers from injury and set to return with Como

Moise Bioty Kean has returned to training after recovering from a leg injury that ruled him out for 3 days, as he prepares for the match against Torino in Serie A.

[Kareem Al-Saleh](https://riyadaty.com/en/author/kareem-al-saleh-2) Editor Published 27 October 2026، 03:42 Saudi time

![Moise Bioty Kean recovers from injury and set to return with Como](https://riyadaty.com/img/blog-1200.jpg/covers/c11ab0e5fe5aab4bc07257ab418f65713fd90f72.webp)

Moise Bioty Kean recovers from injury and set to return with Como

[Como](https://riyadaty.com/en/team/como-234) have announced that their player [Moise Bioty Kean](https://riyadaty.com/en/player/moise-bioty-kean-6823) has recovered from a leg injury that kept him off the pitch for 3 days.

The player had been out since 24 October 2026 due to the injury, before being declared ready to return on 27 October 2026.

The player's return comes at a suitable time ahead of Como's match against Torino in matchday 9 of Serie A for the 2026/27 season.

The match is scheduled to take place on 27 October 2026 at 22:45 Saudi Arabia and Damascus time.

The STARZPLAY platform will broadcast the match for Serie A followers.

[All stories by Kareem Al-Saleh](https://riyadaty.com/en/author/kareem-al-saleh-2) · [Editorial policy](https://riyadaty.com/en/editorial-policy)

## Sign in to join the conversation

Comment, reply to other readers and like what you agree with.

[Sign in](https://riyadaty.com/en/login?redirect=%2Fen%2Fnews%2Fmoise-bioty-kean-recovers-from-injury-and-set-to-return-with-como%23comments) [Create account](https://riyadaty.com/en/register)

No comments yet. Be the first.